Grants for Special district governments - Education

This funding opportunity supports research on how inflammasome activation affects neurocognitive disorders and immune function in individuals with HIV and substance use disorders, encouraging studies that explore the interactions between these factors.

This FOA will support integrated, interdisciplinary research teams that focus on examining dynamic circuit functions related to behavior, using advanced and innovative technologies. The FOA will support programs with a necessarily-synergistic, team science approach. Awards will be made for 5 years, with a possibility of one competing renewal. Applications should incorporate overarching principles of circuit function in the context of specific neural systems underlying sensation, perception, emotion, motivation, cognition, decision-making, motor control, communication, or homeostasis. Applications should incorporate theory-/model-driven experimental design and should offer predictive models as deliverables. Applications should seek to understand circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating relevant dynamic patterns of neural activity and by measuring the resulting behaviors and/or perceptions. Applications are expected to employ approaches guided by specified theoretical constructs, and are encouraged to employ quantitative, mechanistic models where appropriate. Applications will be required to manage their data and analysis methods in a framework that will be developed and used in the proposed U19 project and exchanged with other BRAIN U19 awardees for further refinement and development. Model systems, including the possibility of multiple species ranging from invertebrates to humans, can be employed and should be appropriately justified. Programs should employ multi-component teams of research expertise including neurobiologists, statisticians, physicists, mathematicians, engineers, computer scientists, and data scientists, as appropriate - that seek to cross boundaries of interdisciplinary collaboration. Applicants proposing to include human subjects with invasive neural recording must apply to the companion FOA, RFA-NS-XX-XXX.

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA.

This grant provides funding for innovative researchers focused on addressing and reducing substance use-related health disparities among underserved racial and ethnic minority populations in the U.S.

This funding opportunity supports researchers and organizations developing and testing innovative devices to treat substance use disorders, focusing on their effects on brain function and behavior.

This funding opportunity provides financial support to researchers with active NIH grants to address unexpected costs and enhance their projects without changing the original research scope.

Governor Katie Hobb’s Office of Youth, Faith and Family (GOYFF) issues this Request for  Grant Application (RFGA) Solicitation concerning the Juvenile Justice and Delinquency  Prevention (JJDP) Title II Formula Grant Program per A.R.S. §41-2701. Applications for this program will only be accepted through the state’s web-based grants management system, eCivis. It is anticipated that the results of this RFGA will be announced on September 19, 2024. The deadline for submission of an application in eCivis will be on or before 5:00 PM (Arizona time) on July 25, 2024. Financial Notes: This is a 12-month contract that may be renewable for up to two (2) additional 12-month periods, contingent upon federal appropriations, compliance with terms and conditions, programmatic and financial performance, and submission of a renewal application. It is anticipated (but not guaranteed) that the total funds available will be approximately $600,000 per year. The number of awards will depend on the number and quality of applications received. Qualifying applicants are anticipated to be awarded between $40,000 and $100,000 for the first term. Contracts are anticipated to be effective on October 1, 2024, and end September 30, 2025. Funding will be allocated on a reimbursement basis. No pre-award costs will be considered. The United States Department of Justice, Office of Juvenile Justice and Delinquency  Prevention (OJJDP), provides funding for the Title II Formula Grant. The Catalog of  Federal Domestic Assistance (C.F.D.A.) number for the Juvenile Justice and Delinquency Prevention Title II Formula Grant is 16.540.

This funding opportunity supports research that explores the effects of aging on individuals living with HIV, focusing on improving health outcomes and management strategies for this population.

This funding opportunity supports research projects that explore and address the health disparities related to HIV and substance use among underserved racial and ethnic minority populations in the U.S.

The Illinois Clean Jobs Workforce Network Program is aimed at developing a skilled workforce to support clean jobs in Illinois. The program, funded by the state, is anticipated to offer 13 awards with a total funding amount of $37,900,000. No specific award range is specified. The program is open for applications starting July 7, 2023, and will close on June 30, 2024, at 5:00 PM. Technical assistance for applicants is available, with a session scheduled for July 14, 2023 at 3:00 PM; registration link for the session is provided in the original document.

This funding opportunity supports research projects that investigate individual differences in pain experiences and treatment responses, aiming to develop personalized pain management strategies while addressing the opioid crisis.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that foster a better understanding of biomedical, behavioral and clinical research and its implications. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on research experiences for high school or undergraduate students or science teachers during the summer academic break. The proposed program needs to fit within the mission of the participating IC that the application is being submitted to and should not have a general STEM focus (see below and Table of IC-Specific Information and Points of Contact).

This funding opportunity supports U.S.-based organizations in evaluating the impact of upcoming public policies and programs that aim to improve health behaviors and reduce chronic disease risk factors through behavioral changes.

This grant provides funding for collaborative research projects that investigate how RNA modifications influence cancer development by altering protein synthesis, requiring expertise in RNA biology and cancer research.

This funding opportunity supports innovative research to develop combination cancer therapies that integrate radiation treatment with targeted molecular agents, aimed at improving treatment effectiveness while reducing side effects.

This grant provides funding for researchers, especially those new to the field or looking to integrate advanced data science methods, to explore addiction-related questions using existing data and innovative analytical techniques.

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.

This funding opportunity supports research projects that explore how patients' beliefs and expectations about cancer treatment can improve symptom management, particularly for underserved populations facing unique challenges in care.

This funding opportunity provides resources to organizations that improve transition services for students and youth with disabilities, helping them achieve better outcomes in education and employment.

The "NCI National Clinical Trials Network - Network Lead Academic Participating Sites" grant is a funding opportunity from the National Cancer Institute for academic centers to provide scientific leadership and patient recruitment for large-scale, multi-institutional cancer clinical trials, with a focus on treatment trials, rare cancers, and underserved populations, offering up to $1.7 million per year for a six-year project period.